» Articles » PMID: 33305427

The Role of the Calmodulin-binding and Calmodulin-like Domains of the Epidermal Growth Factor Receptor in Tyrosine Kinase Activation

Abstract

The epidermal growth factor receptor (EGFR) harbors a calmodulin (CaM)-binding domain (CaM-BD) and a CaM-like domain (CaM-LD) upstream and downstream, respectively, of the tyrosine kinase (TK) domain. We demonstrate in this paper that deletion of the positively charged CaM-BD (EGFR/CaM-BD∆) inactivated the TK activity of the receptor. Moreover, deletion of the negatively charged CaM-LD (EGFR/CaM-LD∆), leaving a single negative residue (glutamate), reduced the activity of the receptor. In contrast, substituting the CaM-LD with a histidine/valine-rich peptide (EGFR/InvCaM-LD) caused full inactivation. We also demonstrated using confocal microscopy and flow cytometry that the chimera EGFR-green fluorescent protein (GFP)/CaM-BD∆, the EGFR/CaM-LD∆, and EGFR/InvCaM-LD mutants all bind tetramethylrhodamine-labelled EGF. These EGFR mutants were localized at the plasma membrane as the wild-type receptor does. However, only the EGFR/CaM-LD∆ and EGFR/InvCaM-LD mutants appear to undergo ligand-dependent internalization, while the EGFR-GFP/CaM-BD∆ mutant seems to be deficient in this regard. The obtained results and in silico modelling studies of the asymmetric structure of the EGFR kinase dimer support a role of a CaM-BD/CaM-LD electrostatic interaction in the allosteric activation of the EGFR TK.

Citing Articles

Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways.

Tito C, Genovese I, Giamogante F, Benedetti A, Miglietta S, Barazzuol L Cell Mol Life Sci. 2023; 80(8):202.

PMID: 37442828 PMC: 10345051. DOI: 10.1007/s00018-023-04850-4.


Regulation of ErbB Receptors by the Ca Sensor Protein Calmodulin in Cancer.

Villalobo A Biomedicines. 2023; 11(3).

PMID: 36979639 PMC: 10045772. DOI: 10.3390/biomedicines11030661.